Bellerophon Therapeutics competitors

Bellerophon Therapeutics Competitors include ITeos Therapeutics, MultiCell Technologies, Hedgepath Pharmaceuticals and Syneos Health.
Add company...
Bellerophon Therapeutics
Bellerophon Therapeutics
Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products at the intersection of drugs and devices that address significant unmet medical needs in the treatment of cardiopulmonary diseases.
ITeos Therapeutics
ITeos Therapeutics
ITeos Therapeutics is a biopharmaceutical company whose work is dedicated to designing and developing next generation immunotherapies.
MultiCell Technologies
MultiCell Technologies
MultiCell Technologies, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics and discovery tools that address unmet medical needs for the treatment of neurological disorders, hepatic disease and cancer.
Hedgepath Pharmaceuticals
Hedgepath Pharmaceuticals
HedgePath Pharma is a clinical stage biopharma company that discovers, develops & plans to commercialize innovative therapeutics for patients with cancer.
Syneos Health
Syneos Health
Syneos Health, a contract research organization, provides various clinical development services for the biopharmaceutical and medical device industries.
Founding Date
Founding Date
2009
Founding Date
2011
Founding Date
1962
Founding Date
1992
Founding Date
2010
Type
Type
Public
Type
Private
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Warren, US HQ
Locations
Charleroi, BE HQ
Cambridge, US
Locations
Woonsocket, US HQ
Locations
Tampa, US HQ
Locations
Raleigh, US HQ
Employees
Employees
209% decrease
Employees
434% decrease
Employees
2
Employees
9
Employees
6,800
Valuation ($)
Valuation ($)
63.4 m
Valuation ($)
N/A
Valuation ($)
716.9 k
Valuation ($)
5.2 m
Valuation ($)
4.5 b
Twitter followers
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
57
Twitter followers
12.1 k

Financial

Net income
Net income
($54.8m) (FY, 2017)
Net income
N/A
Net income
N/A
Net income
($5.1m) (FY, 2017)
Net income
($138.5m) (FY, 2017)

Funding

Total funding raised
Total funding raised
$ 80m
Total funding raised
$ 78.1m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

ITeos Therapeutics
HQ
Charleroi, BE
Employees
43↓ 4% decrease

ITeos Therapeutics is a biopharmaceutical company whose work is dedicated to designing and developing next generation immunotherapies.

View company
MultiCell Technologies
HQ
Woonsocket, US
Employees
2

MultiCell Technologies, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics and discovery tools that address unmet medical needs for the treatment of neurological disorders, hepatic disease and cancer.

View company
Hedgepath Pharmaceuticals
HQ
Tampa, US
Employees
9

HedgePath Pharma is a clinical stage biopharma company that discovers, develops & plans to commercialize innovative therapeutics for patients with cancer.

View company
Syneos Health
HQ
Raleigh, US
Employees
6,800

Syneos Health, a contract research organization, provides various clinical development services for the biopharmaceutical and medical device industries.

View company